| Celebrating Boston Life Sciences: Xconomy Awards Gala Slideshow | Corie Lok | 10/03/17 | Boston |
| Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists | Corie Lok | 08/14/17 | Boston |
| Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics | Frank Vinluan | 03/08/17 | Boston |
| East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More | Ben Fidler | 02/05/16 | Boston |
| Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs | Ben Fidler | 02/02/16 | Boston |
| From Dance Clubs to Syn Bio: MIT’s Collins on Startups, Second Chances | Ben Fidler | 10/05/15 | Boston |
| Five Takeaways From “Boston’s Life Science Disruptors” | Ben Fidler | 10/02/15 | Boston |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| With $30M, Spero Broadens Fight Against Drug-Resistant Bugs | Ben Fidler | 06/08/15 | Boston |
| Ex-Pfizer Exec Gutierrez-Ramos to Lead Synlogic’s “Smart Bug” Plan | Ben Fidler | 05/21/15 | Boston |
| Smart-Bug Maker Synlogic Nabs $5M From Gates Foundation | Ben Fidler | 10/07/14 | Boston |
| Synlogic Gets $30M From Atlas, NEA to Turn Smart Bugs Into Drugs | Ben Fidler | 07/22/14 | Boston |
| Rodin Moves From Seedling to Neurology Startup With $12.9M Series A | Ben Fidler | 05/29/14 | Boston |
| Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs | Ben Fidler | 04/09/14 | Boston |
